{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:51:28Z","timestamp":1762541488164,"version":"build-2065373602"},"reference-count":73,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.hoc.2005.07.006","type":"journal-article","created":{"date-parts":[[2005,11,7]],"date-time":"2005-11-07T10:44:29Z","timestamp":1131360269000},"page":"839-855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Overt and Incomplete (Silent) Cerebral Infarction in Sickle Cell Anemia: Diagnosis and Management"],"prefix":"10.1016","volume":"19","author":[{"given":"Wing-Yen","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darleen R.","family":"Powars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2005.07.006_bib1","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1001\/archneur.58.12.2017","article-title":"Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity","volume":"58","author":"Pegelow","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.hoc.2005.07.006_bib2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ana.10192","article-title":"Sickle cell disease: the neurological complications","volume":"51","author":"Prengler","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.hoc.2005.07.006_bib3","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jama.280.12.1055","article-title":"Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion","volume":"280","author":"Grubb","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2005.07.006_bib4","first-page":"228","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.006_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0002-9343(78)90772-6","article-title":"The natural history of stroke in sickle cell disease","volume":"65","author":"Powars","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.hoc.2005.07.006_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/asheducation-2001.1.31","article-title":"Sickle cell and the brain","author":"Adams","year":"2001","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1016\/j.hoc.2005.07.006_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00043426-200007000-00010","article-title":"Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease","volume":"22","author":"Wang","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.hoc.2005.07.006_bib8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1148\/radiol.2281020943","article-title":"Brain imaging findings in pediatric patients with sickle cell disease","volume":"228","author":"Steen","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.hoc.2005.07.006_bib9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/01.STR.27.4.761","article-title":"Ischemic stroke and incomplete infarction","volume":"27","author":"Garcia","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.hoc.2005.07.006_bib10","first-page":"71","article-title":"Vascular lesions in the central nervous system in sickle cell disease (neuropathology)","volume":"1","author":"Koshy","year":"1990","journal-title":"JAAMP"},{"key":"10.1016\/j.hoc.2005.07.006_bib11","first-page":"71","article-title":"Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography","volume":"93","author":"Powars","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.006_bib12","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood.V101.6.2401","article-title":"Stroke risk in siblings with sickle cell anemia","volume":"101","author":"Driscoll","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.006_bib13","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1182\/blood-2002-09-2791","article-title":"Distinct HLA associations by stroke in children with sickle cell anemia","volume":"101","author":"Hoppe","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.006_bib14","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/00043426-200308000-00007","article-title":"Alpha thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia","volume":"25","author":"Hsu","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.hoc.2005.07.006_bib15","first-page":"392","article-title":"Transport of N-acetylaspartate by the Na+-dependent high-affinity dicarboxylate transporter NaDC3 and its relevance to the expression of the transporter in the brain","volume":"295","author":"Huang","year":"2000","journal-title":"Pharmacology"},{"key":"10.1016\/j.hoc.2005.07.006_bib16","first-page":"463","article-title":"Abnormally high levels of brain N-acetylaspartate in children with sickle cell disease","volume":"26","author":"Steen","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.hoc.2005.07.006_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM200001133420203","article-title":"Prediction of adverse outcomes in children with sickle cell disease: a report from the Cooperative Study (CSSCD)","volume":"342","author":"Miller","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.07.006_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/088307389501000203","article-title":"Accuracy of neurologic examination and history in detecting evidence of MRI-diagnosed cerebral infarctions in children with sickle cell hemoglobinopathy","volume":"10","author":"Glauser","year":"1995","journal-title":"J Child Neurol"},{"key":"10.1016\/j.hoc.2005.07.006_bib19","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0022-3476(98)70397-X","article-title":"Abnormalities of the central nervous system in very young children with sickle cell anemia","volume":"132","author":"Wang","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.hoc.2005.07.006_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1067\/mpd.2001.117580","article-title":"Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease","volume":"139","author":"Miller","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.hoc.2005.07.006_bib21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1067\/mpd.2002.122498","article-title":"Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke","volume":"140","author":"Scothorn","year":"2002","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.hoc.2005.07.006_bib22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ana.97","article-title":"Perfusion magnetic resonance abnormalities in patients with sickle cell disease","volume":"49","author":"Kirkham","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.hoc.2005.07.006_bib23","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1182\/blood.V99.9.3144","article-title":"Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events","volume":"99","author":"Dobson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.006_bib24","first-page":"1077","article-title":"Neuropsychologic impairment in children with sickle cell anemia","volume":"84","author":"Swift","year":"1989","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.hoc.2005.07.006_bib25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archneur.58.4.565","article-title":"Stroke prevention and treatment in sickle cell disease","volume":"58","author":"Adams","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.hoc.2005.07.006_bib26","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1182\/blood-2003-11-3758","article-title":"Survival of children with sickle cell disease","volume":"103","author":"Quinn","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.006_bib27","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1046\/j.1365-2141.2000.01912.x","article-title":"Management of cerebral vasculopathy in children with sickle cell anaemia","volume":"l108","author":"Powars","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2005.07.006_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.51.1.169","article-title":"Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study","volume":"51","author":"Earley","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.hoc.2005.07.006_bib29","first-page":"924","article-title":"Time lag to diagnosis of stroke in children","volume":"110","author":"Gabis","year":"2002","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.hoc.2005.07.006_bib30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/1355785022000038597","article-title":"Knowledge of stroke risk, signs of stroke, and the need for stroke education among children with sickle cell disease and their caregivers","volume":"7","author":"Katz","year":"2002","journal-title":"Ethn Health"},{"key":"10.1016\/j.hoc.2005.07.006_bib31","first-page":"864","article-title":"Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease","volume":"97","author":"Armstrong","year":"1996","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.hoc.2005.07.006_bib32","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0022-3476(05)80844-3","article-title":"Neuropsychologic effects of stroke in children with sickle cell anemia","volume":"123","author":"Craft","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.hoc.2005.07.006_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/088307380001500510","article-title":"Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation","volume":"15","author":"Bernaudin","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.hoc.2005.07.006_bib34","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/08830738020170122401","article-title":"Lesion burden and cognitive morbidity in children with sickle cell disease","volume":"17","author":"Schatz","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.hoc.2005.07.006_bib35","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1182\/blood.V99.8.3014","article-title":"Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease","volume":"99","author":"Pegelow","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.006_bib36","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/088307380001500511","article-title":"Lessons from the stroke prevention trial in sickle cell anemia (STOP) study","volume":"15","author":"Adams","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.hoc.2005.07.006_bib37","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1182\/blood-2003-06-1972","article-title":"Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study","volume":"103","author":"Abboud","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.006_bib38","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa022066","article-title":"Silent brain infarcts and the risk of dementia and cognitive decline","volume":"348","author":"Vermeer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.07.006_bib39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1148\/radiology.206.2.9457180","article-title":"Sickle cell disease: imaging of cerebrovascular complications","volume":"206","author":"Moran","year":"1998","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.hoc.2005.07.006_bib40","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1148\/radiol.2242010873","article-title":"CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department","volume":"224","author":"Mullins","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.hoc.2005.07.006_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0899-7071(03)00121-9","article-title":"Sickle cell cerebrovascular disease: usual and unusual findings on MR imaging and MR angiography","volume":"28","author":"Moritani","year":"2004","journal-title":"Clin Imag"},{"key":"10.1016\/j.hoc.2005.07.006_bib42","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jmri.1880080304","article-title":"Quantitative MRI of the brain in children with sickle cell disease reveals abnormalities unseen by conventional MRI","volume":"8","author":"Steen","year":"1998","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.hoc.2005.07.006_bib43","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.STR.0000061496.00669.5E","article-title":"Detection of diffusion-weighted MRI abnormalities in patients with transient ischemic attack: correlation with clinical characteristics","volume":"34","author":"Crisostomo","year":"2003","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.hoc.2005.07.006_bib44","first-page":"436","article-title":"Assessing tissue viability with MR diffusion and perfusion imaging","volume":"24","author":"Schaefer","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.hoc.2005.07.006_bib45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF00607263","article-title":"Comparison of magnetic resonance angiography and conventional angiography in sickle cell disease: clinical significance and reliability","volume":"38","author":"Kandeel","year":"1996","journal-title":"Neuroradiology"},{"key":"10.1016\/j.hoc.2005.07.006_bib46","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood-2003-08-2733","article-title":"Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study","volume":"103","author":"Adams","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.006_bib47","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1161\/01.STR.25.11.2153","article-title":"Middle cerebral artery velocity changes during transfusion in sickle cell anemia","volume":"25","author":"Venketasubramanian","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.hoc.2005.07.006_bib48","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1148\/radiology.196.3.7644642","article-title":"Acute subarachnoid hemorrhage: MR imaging with fluid-attenuated inversion recovery pulse sequences","volume":"196","author":"Noguchi","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/j.hoc.2005.07.006_bib49","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1182\/blood-2002-08-2617","article-title":"Induction of fetal hemoglobin expression by the histone-deacetylase inhibitor apicidin","volume":"101","author":"Witt","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.006_bib50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jpeds.2004.06.032","article-title":"Expanding the role of hydroxyurea in children with sickle cell disease","volume":"145","author":"Rogers","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.hoc.2005.07.006_bib51","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200009073431007","article-title":"Treatment of acute ischemic stroke","volume":"343","author":"Brott","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2005.07.006_bib52","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(01)05966-9","article-title":"Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomized, double-blind study","volume":"358","author":"Scheidtmann","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2005.07.006_bib53","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00004647-199609000-00007","article-title":"Age dependence of total cerebral blood flow volume from childhood to adulthood","volume":"16","author":"Schoning","year":"1996","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"10.1016\/j.hoc.2005.07.006_bib54","first-page":"615","article-title":"Cerebral blood flow in sickle cerebrovascular disease","volume":"73","author":"Huttenlocher","year":"1984","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.hoc.2005.07.006_bib55","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00043426-200405000-00004","article-title":"Assessment of cerebral tissue oxygenation in patients with sickle cell disease: effect of transfusion therapy","volume":"26","author":"Raj","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.hoc.2005.07.006_bib56","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0022-3476(83)80716-1","article-title":"Recurrent cerebral ischemia during hypertransfusion therapy in sickle cell anemia","volume":"103","author":"Buchanan","year":"1983","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.hoc.2005.07.006_bib57","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(95)70204-0","article-title":"Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions","volume":"126","author":"Pegelow","year":"1995","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.hoc.2005.07.006_bib58","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood.V63.1.162.162","article-title":"Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease","volume":"63","author":"Russell","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.006_bib59","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1182\/blood.V79.7.1657.1657","article-title":"A modified transfusion program for prevention of stroke in sickle cell disease","volume":"79","author":"Cohen","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.006_bib60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0037-1963(01)90060-5","article-title":"Progression of iron overload in sickle cell disease","volume":"38","author":"Olivieri","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.hoc.2005.07.006_bib61","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V94.9.3022","article-title":"Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease","volume":"94","author":"Ware","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.006_bib62","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ajh.10205","article-title":"Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA)","volume":"71","author":"Sumoza","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hoc.2005.07.006_bib63","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1182\/blood-2003-07-2475","article-title":"Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease","volume":"103","author":"Zimmerman","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2005.07.006_bib64","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","article-title":"Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment","volume":"289","author":"Steinberg","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2005.07.006_bib65","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0022-3476(97)70108-2","article-title":"Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke","volume":"131","author":"Rana","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.hoc.2005.07.006_bib66","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jpeds.2004.04.058","article-title":"Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy","volume":"145","author":"Ware","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.hoc.2005.07.006_bib67","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1067\/mpd.2001.119590","article-title":"A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia","volume":"139","author":"Wang","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.hoc.2005.07.006_bib68","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S1053-8119(03)00369-0","article-title":"Functional cerebral reorganization following motor sequence learning through mental practice with motor imagery","volume":"20","author":"Jackson","year":"2003","journal-title":"Neuroimage"},{"key":"10.1016\/j.hoc.2005.07.006_bib69","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0003-9993(03)00042-X","article-title":"Using motor imagery in the rehabilitation of hemiparesis","volume":"84","author":"Stevens","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.hoc.2005.07.006_bib70","first-page":"237","article-title":"Constraint-induced movement therapy: a new family of techniques with broad application to physical rehabilitation. A clinical review","volume":"36","author":"Taub","year":"1999","journal-title":"J Rehab Res Dev"},{"key":"10.1016\/j.hoc.2005.07.006_bib71","series-title":"Plasticity and rehabilitation","first-page":"77","article-title":"Motor control and learning principles for rehabilitation of upper limb movements after brain injury","author":"Winstein","year":"2003"},{"key":"10.1016\/j.hoc.2005.07.006_bib72","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1161\/01.STR.30.11.2369","article-title":"Forced use of the upper extremity in chronic stroke patients: results from a single-blind randomized clinical trial","volume":"30","author":"van der Lee","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.hoc.2005.07.006_bib73","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/S0317167100052173","article-title":"Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier?","volume":"27","author":"Gladstone","year":"2000","journal-title":"Can J Neurol Sci"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858805000870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858805000870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:37:17Z","timestamp":1760182637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858805000870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0889858805000870"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2005.07.006","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overt and Incomplete (Silent) Cerebral Infarction in Sickle Cell Anemia: Diagnosis and Management","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2005.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}